Ennio Tasciotti is a globally recognized biomedical scientist and pioneer in biomimetic and regenerative medicine, with over 25 years of experience across research, clinical translation, and innovation.
He is Director of the Human Longevity Program at IRCCS San Raffaele and Professor at San Raffaele University. Ranked among the top 1% of the world’s most influential scientists by Stanford University, he has authored 200+ publications, holds 14 international patents, and has received over 12,000 citations.
Previously, he spent 15 years in the U.S. as Chairman of the Department of Nanomedicine and founder and director of two research centers at Houston Methodist Hospital and Research Institute. His work bridges engineering and medicine, with key advances in tissue regeneration, immune modulation, and targeted drug delivery.
Ennio is also founder and CSO of three biomedical startups and advises leading global healthcare companies on innovation in medical devices, biopharma, and digital health.